Neuropathic pain in primary care

References

• Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986; 3: S1–S226.
   PubMedGoogle Scholar
• Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006; 7(4): 281–289.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Backonja M, Rowbotham MC. Advances in neuropathic pain. Diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60(11): 1524–1534.
   PubMed Web of Science ®Google Scholar
• Rice ASC, Hill RG. New treatment for neuropathic pain. Annu Rev Med. 2006; 57: 535–551.
   PubMed Web of Science ®Google Scholar
• Booker CK, Keen A. Illness and treatment experiences of patients with peripheral neuropathy and neuropathic pain. Manchester: Pain Society Annual Scientific Meeting; 2004.
   Google Scholar
• Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002; 18(6): 350–354.
   PubMed Web of Science ®Google Scholar
• Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002; 18(6): 343–349.
   PubMed Web of Science ®Google Scholar
• Chen H, Lamer TJ, Rho RH, et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc. 2004; 79(12): 1533–1545.
   PubMed Web of Science ®Google Scholar
• Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000; p. 175–186, 207–228.
   Google Scholar
• Galluzzi K. Management of neuropathic pain. J Am Osteopath Assoc. 2005; 105(9 Suppl 4): S12-S19 [homepage on the Internet]. c2012. Available from: http://www.jaoa.org/content/105/suppl_4/S12.full
   Google Scholar
• Ji R-R, Strichartz G. Cell signaling and the genesis of neuropathic pain. Science's STKE. 2004; 2004(252): reE14 [homepage on the Internet]. c2012. Available from: http://www.stke.science.mag.org/cgi/content/full/2004/252/re14.
   PubMedGoogle Scholar
• Spruce MC, Potter J, Coppini DV. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med. 2003;20(2): 88–98.
   PubMed Web of Science ®Google Scholar
• Boureau F, Doubrere JF, Luu M. Study of verbal description in neuropathic pain. Pain. 1990; 42(2):145–152.
   PubMed Web of Science ®Google Scholar
• Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998; 280(21): 1831–1836.
   PubMed Web of Science ®Google Scholar
• Namaka M, Gramlich CR, Ruhlen D, et al. A treatment algorithm for neuropathic pain. Clin Ther. 2004;26(7):951–979.
   PubMed Web of Science ®Google Scholar
• Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. [Cochrane review]. In: The Cochrane Library, Issue 3, 2005; p. 1–48. Oxford: Update Software.
   Google Scholar
• Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. [Cochrane review]. In: The Cochrane Library, Issue 3, 2005; p. 1–24. Oxford: Update Software.
   Google Scholar
• Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain. 1999; 3(4):335–342.
   PubMed Web of Science ®Google Scholar
• Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002; 59(7): 1015–1021.
   PubMed Web of Science ®Google Scholar
• Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998; 280(21): 1831–1836.
   PubMed Web of Science ®Google Scholar
• Katz NP, Gammaitoni AR, Davis MW, et al. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med. 2002; 3(4): 324–332.
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003; 43(2): 111–117.
   PubMed Web of Science ®Google Scholar
• Bennett GJ. Neuropathic pain: an overview. In: Borsook D, editor. Molecular neurobiology of pain. Seattle: IASP Press, 1997; p. 109–113.
   Google Scholar
• Harati Y, Gooch C, Swenson M, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000; 14(2): 65–70.
   PubMed Web of Science ®Google Scholar
• Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003; 60(6): 927–934.
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003; 348(13): 1223–1232.
   PubMed Web of Science ®Google Scholar
• Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004; 112(3): 372–380.
   PubMed Web of Science ®Google Scholar
• Kieburtz K, Simpson D, Yiannoutsos D, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology. 1998; 51(6): 1682–1688.
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Dongsheng Tu, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005; 352(13): 1324–1334.
   PubMed Web of Science ®Google Scholar